Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Pulmonary Medicine, enter your email address in the box below.

Pulmonary Medicine
Volume 2012, Article ID 745483, 10 pages
http://dx.doi.org/10.1155/2012/745483
Review Article

Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis

Yone Vila Nova Cavalcanti,1,2 Maria Carolina Accioly Brelaz,2 Juliana Kelle de Andrade Lemoine Neves,2 José Candido Ferraz,3 and Valéria Rêgo Alves Pereira2

1Departamento de Biologia, UFRPE, Dom Manoel de Medeiros, S/N, Dois Irmãos, 52171-900 Recife, PE, Brazil
2Departamento de Imunologia, Centro de Pesquisas Aggeu Magalhães (CPqAM/FIOCRUZ), Avenida Professor Moraes Rego S/N, Cidade Universitária, Campus da UFPE, 50670-420 Recife, PE, Brazil
3Núcleo de Educação Física e Ciências do Esporte, Centro Acadêmico de Vitória, Universidade Federal de Pernanbuco (UFPE), Vitória de Santo Antão, PE, Brazil

Received 30 August 2012; Revised 31 October 2012; Accepted 5 November 2012

Academic Editor: José R. Lapa e Silva

Copyright © 2012 Yone Vila Nova Cavalcanti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. Sato, “Mycobacterium,” in Bacteriologia—um texto ilustrado, C. H. P. M. e Silva, Ed., pp. 285–315, Eventos, Rio de Janeiro, Brazil, 1999. View at Google Scholar
  2. WHO, Global Tuberculosis Control, 2011.
  3. WHO, The Global Plan Tuberculosis to Stop TB, 2011–2015, 2012.
  4. M. Baliza, A. H. Bach, G. L. de Queiroz et al., “High frequency of resistance to the drugs isoniazid and rifampicin among tuberculosis cases in the City of Cabo de Santo Agostinho, an urban area in Northeastern Brazil,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 1, pp. 11–16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Tomioka, Y. Tatano, C. Sano, and T. Shimizu, “Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks,” Journal of Infection and Chemotherapy, vol. 17, no. 3, pp. 302–317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Corbett, C. J. Watt, N. Walker et al., “The growing burden of tuberculosis: global trends and interactions with the HIV epidemic,” Archives of Internal Medicine, vol. 163, no. 9, pp. 1009–1021, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. R. Frieden, T. R. Sterling, S. S. Munsiff, C. J. Watt, and C. Dye, “Tuberculosis,” The Lancet, vol. 362, no. 9387, pp. 887–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. E. Dooley and R. E. Chaisson, “Tuberculosis and diabetes mellitus: convergence of two epidemics,” The Lancet Infectious Diseases, vol. 9, no. 12, pp. 737–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Kinjo, K. Kawakami, K. Uezu et al., “Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40,” Journal of Immunology, vol. 169, no. 1, pp. 323–329, 2002. View at Google Scholar · View at Scopus
  10. C. H. Wang, H. C. Lin, C. Y. Liu et al., “Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 3, pp. 283–291, 2001. View at Google Scholar · View at Scopus
  11. A. Gupta, A. Kaul, A. G. Tsolaki, U. Kishore, and S. Bhakta, “Mycobacterium tuberculosis: immune evasion, latency and reactivation,” Immunobiology, vol. 217, no. 3, pp. 363–374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Cooper and S. A. Khader, “The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis,” Immunological Reviews, vol. 226, no. 1, pp. 191–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Lawn, L. Myer, D. Edwards, L. G. Bekker, and R. Wood, “Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa,” AIDS, vol. 23, no. 13, pp. 1717–1725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Khader, G. K. Bell, J. E. Pearl et al., “IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge,” Nature Immunology, vol. 8, no. 4, pp. 369–377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. G. Lin and J. L. Flynn, “Understanding latent tuberculosis: a moving target,” Journal of Immunology, vol. 185, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kader, X. Wang, M. Piatak et al., “α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection,” Mucosal Immunology, vol. 2, no. 5, pp. 439–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Torrado and A. M. Cooper, “IL-17 and Th17 cells in tuberculosis,” Cytokine and Growth Factor Reviews, vol. 21, no. 6, pp. 455–462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. M. Wozniak, B. M. Saunders, A. A. Ryan, and W. J. Britton, “Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of γ interferon,” Infection and Immunity, vol. 78, no. 10, pp. 4187–4194, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. I. L. D. Moutinho, “Tuberculose: aspectos imunológicos na infecção e na doença,” Revista Médica de Minas Gerais, vol. 21, no. 1, pp. 42–48, 2011. View at Google Scholar
  22. C. A. Dinarello, “Immunological and inflammatory functions of the interleukin-1 family,” Annual Review of Immunology, vol. 27, pp. 519–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Garlanda, D. Di Liberto, A. Vecchi et al., “Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling,” Journal of Immunology, vol. 179, no. 5, pp. 3119–3125, 2007. View at Google Scholar · View at Scopus
  24. D. M.-B. Katrin, B. B. Andrade, D. L. Barber et al., “Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection,” Immunity, vol. 35, no. 6, pp. 1023–1034, 2011. View at Publisher · View at Google Scholar
  25. R. Guler, S. P. Parihar, G. Spohn, P. Johansen, F. Brombacher, and M. F. Bachmann, “Blocking IL-1α but not IL-1β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice,” Vaccine, vol. 29, no. 6, pp. 1339–1346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Carswell, L. J. Old, Kassel, R. L. Green, N. Fiore, and B. Williamson, “An endotoxin-induced serum factor that causes necrosis of tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 9, pp. 3666–3670, 1975. View at Publisher · View at Google Scholar
  27. P. F. Barnes, S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin, “Cytokine production at the site of disease in human tuberculosis,” Infection and Immunity, vol. 61, no. 8, pp. 3482–3489, 1993. View at Google Scholar · View at Scopus
  28. C. H. Ladel, G. Szalay, D. Riedel, and S. H. E. Kaufmann, “Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages,” Infection and Immunity, vol. 65, no. 5, pp. 1936–1938, 1997. View at Google Scholar · View at Scopus
  29. N. V. Serbina and J. L. Flynn, “Early emergence of CD8+ T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice,” Infection and Immunity, vol. 67, no. 8, pp. 3980–3988, 1999. View at Google Scholar · View at Scopus
  30. K. Yu, C. Mitchell, Y. Xing, R. S. Magliozzo, B. R. Bloom, and J. Chan, “Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion,” Tubercle and Lung Disease, vol. 79, no. 4, pp. 191–198, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. Scanga, V. P. Mohan, K. Yu et al., “Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2,” Journal of Experimental Medicine, vol. 192, no. 3, pp. 347–358, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. V. P. Mohan, C. A. Scanga, K. Yu et al., “Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology,” Infection and Immunity, vol. 69, no. 3, pp. 1847–1855, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Flynn, M. M. Goldstein, J. Chan et al., “Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice,” Immunity, vol. 2, no. 6, pp. 561–572, 1995. View at Google Scholar · View at Scopus
  34. A. G. D. Bean, D. R. Roach, H. Briscoe et al., “Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin,” Journal of Immunology, vol. 162, no. 6, pp. 3504–3511, 1999. View at Google Scholar · View at Scopus
  35. J. L. Flynn, C. A. Scanga, K. E. Tanaka, and J. Chan, “Effects of aminoguanidine on latent murine tuberculosis,” Journal of Immunology, vol. 160, no. 4, pp. 1796–1803, 1998. View at Google Scholar · View at Scopus
  36. D. Dlugovitzky, M. L. Bay, L. Rateni et al., “Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB),” Clinical and Experimental Immunology, vol. 122, no. 3, pp. 343–349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Al-Attiyah, A. El-Shazly, and A. S. Mustafa, “Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients,” Scandinavian Journal of Immunology, vol. 75, no. 6, pp. 623–632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. E. P. Moura, “Avaliação da resposta immune cellular e humoral antes e depois do tratamento da tuberculose pulmonar,” Tese, p. 90, 2002.
  39. E. Juárez, C. Carranza, F. Hernández-Sánchez et al., “NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans,” European Journal of Immunology, vol. 42, no. 4, pp. 880–889, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. N. Maini, P. C. Taylor, E. Paleolog et al., “Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 58, no. 1, pp. I56–I60, 1999. View at Google Scholar · View at Scopus
  41. I. Solovic, M. Sester, J. J. Gomez-Reino et al., “The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement,” European Respiratory Journal, vol. 36, no. 5, pp. 1185–1206, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Stallmach, S. Hagel, and T. Bruns, “Adverse effects of biologics used for treating IBD,” Best Practice and Research: Clinical Gastroenterology, vol. 24, no. 2, pp. 167–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. L. Flynn, J. Chan, and P. L. Lin, “Macrophages and control of granulomatous inflammation in tuberculosis,” Mucosal Immunology, vol. 4, no. 3, pp. 271–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. L. G. Bekker, A. L. Moreira, A. Bergtold, S. Freeman, B. Ryffel, and G. Kaplan, “Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent,” Infection and Immunity, vol. 68, no. 12, pp. 6954–6961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Ehlers, J. Benini, H. D. Held, C. Roeck, G. Alber, and S. Uhlig, “αβ T cell receptor-positive cells and interferon-γ, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1847–1859, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Jönsson, M. Ridell, and A. E. Wold, “Phagocytosis and cytokine response to rough and smooth colony variants of mycobacterium abscessus byhuman peripheral blood mononuclear cells,” Acta Pathologica, Microbiologica et Immunologica Scandinavica. In press. View at Publisher · View at Google Scholar
  47. I. Dambuza, N. Allie, L. Fick et al., “Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence,” Tuberculosis, vol. 88, no. 3, pp. 221–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Keane, H. G. Remold, and H. Kornfeld, “Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages,” Journal of Immunology, vol. 164, no. 4, pp. 2016–2020, 2000. View at Google Scholar · View at Scopus
  49. C. M. Robinson, J. Y. Jung, and G. J. Nau, “Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages,” Cytokine, vol. 60, no. 1, pp. 233–241, 2012. View at Publisher · View at Google Scholar
  50. C. Manca, M. B. Reed, S. Freeman et al., “Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis,” Infection and Immunity, vol. 72, no. 9, pp. 5511–5514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. van Kooyk and T. B. H. Geijtenbeek, “DC-SIGN: escape mechanism for pathogens,” Nature Reviews Immunology, vol. 3, no. 9, pp. 697–709, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. G. T. Seah and G. A. W. Rook, “IL-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-α,” Journal of Immunology, vol. 167, no. 3, pp. 1230–1237, 2001. View at Google Scholar · View at Scopus
  53. S. Stenger, “Immunological control of tuberculosis: role of tumour necrosis factor and more,” Annals of the Rheumatic Diseases, vol. 64, supplement 4, pp. iv24–iv28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Bocchino, D. Galati, A. Sanduzzi, V. Colizzi, E. Brunetti, and G. Mancino, “Role of mycobacteria-induced monocyte/macrophage apoptosis in the pathogenesis of human tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 9, no. 4, pp. 375–383, 2005. View at Google Scholar · View at Scopus
  55. A. Isaacs, J. Lindenmann, and R. C. Valentine, “Virus interference. II. Some properties of interferon,” Proceedings of the Royal Society of London, Series B, vol. 1471, no. 927, pp. 268–273, 1957. View at Google Scholar
  56. G. H. Schreiber and R. D. Schereiber, “Interferon-γ,” in The Cytokine Handbook, A. W. Thomson and M. T. Lotze, Eds., vol. 1, chapter 24, pp. 567–601, Elsevier, New York, NY, USA, 4th edition.
  57. I. E. A. Flesch, J. H. Hess, S. Huang et al., “Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α,” Journal of Experimental Medicine, vol. 181, no. 5, pp. 1615–1621, 1995. View at Google Scholar · View at Scopus
  58. M. J. Fenton, M. W. Vermeulen, S. Kim, M. Burdick, R. M. Strieter, and H. Kornfeld, “Induction of γ interferon production in human alveolar macrophages by Mycobacterium tuberculosis,” Infection and Immunity, vol. 65, no. 12, pp. 5149–5156, 1997. View at Google Scholar · View at Scopus
  59. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Cytokine signaling—regulation of the immune response in normal and critically ill states,” Critical Care Medicine, vol. 28, no. 4, supplement, pp. N3–N12, 2000. View at Google Scholar · View at Scopus
  60. A. M. Cooper, “Cell-mediated immune responses in tuberculosis,” Annual Review of Immunology, vol. 27, pp. 393–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. A. J. Gehring, R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom, “The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits γ interferon-regulated HLA-DR and FcγR1 on human macrophages through toll-like receptor 2,” Infection and Immunity, vol. 71, no. 8, pp. 4487–4497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. C. V. Harding, R. K. Pai, M. Convery, T. A. Hamilton, and W. Henry Boom, “Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion,” Journal of Immunology, vol. 171, no. 1, pp. 175–184, 2003. View at Google Scholar · View at Scopus
  63. R. C. O. Tavares, J. Salgado, V. B. Moreira et al., “Cell proliferation and interferon-γ response to recombinant MBP-3, NarL, MT-10.3, and 16kDa Mycobacterium tuberculosis antigens in Brazilian tuberculosis patients,” Memorias do Instituto Oswaldo Cruz, vol. 101, no. 8, pp. 857–861, 2006. View at Google Scholar · View at Scopus
  64. A. Nienhaus, A. Schablon, and R. Diel, “Interferon-γ release assay for the diagnosis of latent TB infection—analysis of discordant results, when compared to the tuberculin skin test,” PLoS ONE, vol. 3, no. 7, Article ID e2665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. C. T. Costa, R. Silva, R. Sá, M. J. Cardoso, C. Ribeiro, and A. Nienhaus, “Comparison of interferon-γ release assay and tuberculin test for screening in healthcare workers,” Revista Portuguesa de Pneumologia, vol. 16, no. 2, pp. 211–221, 2010. View at Google Scholar · View at Scopus
  66. A. M. Cooper, D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme, “Disseminated tuberculosis in interferon γ gene-disrupted mice,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2243–2247, 1993. View at Publisher · View at Google Scholar · View at Scopus
  67. J. L. Flynn, J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, “An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2249–2254, 1993. View at Publisher · View at Google Scholar · View at Scopus
  68. M. J. Newport, C. M. Huxley, S. Huston et al., “A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection,” The New England Journal of Medicine, vol. 335, no. 26, pp. 1941–1949, 1996. View at Publisher · View at Google Scholar · View at Scopus
  69. T. H. M. Ottenhoff, F. A. W. Verreck, M. A. Hoeve, and E. van de Vosse, “Control of human host immunity to mycobacteria,” Tuberculosis, vol. 85, no. 1-2, pp. 53–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Jouanguy, F. Altare, S. Lamhamedi et al., “Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection,” The New England Journal of Medicine, vol. 335, no. 26, pp. 1956–1961, 1996. View at Google Scholar · View at Scopus
  71. J. L. Casanova and L. Abel, “Genetic dissection of immunity to mycobacteria: the human model,” Annual Review of Immunology, vol. 20, pp. 581–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. G. S. Cooke and A. V. S. Hill, “Genetics of susceptibility to human infectious disease,” Nature Reviews Genetics, vol. 2, no. 12, pp. 967–977, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. H. M. S. Algood, J. Chan, and J. L. Flynn, “Chemokines and tuberculosis,” Cytokine and Growth Factor Reviews, vol. 14, no. 6, pp. 467–477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. V. E. García, K. Uyemura, P. A. Sieling et al., “IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection,” Journal of Immunology, vol. 162, no. 10, pp. 6114–6121, 1999. View at Google Scholar · View at Scopus
  75. R. Vankayalapati, B. Wizel, S. E. Weis, B. Samten, W. M. Girard, and P. F. Barnes, “Production of interleukin-18 in human tuberculosis,” Journal of Infectious Diseases, vol. 182, no. 1, pp. 234–239, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. I. Sugawara, H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira, “Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18- gene-disrupted mice,” Infection and Immunity, vol. 67, no. 5, pp. 2585–2589, 1999. View at Google Scholar · View at Scopus
  77. M. Morosini, F. Meloni, A. M. Bianco et al., “The assessment of IFN-γ and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 10, pp. 994–1000, 2003. View at Google Scholar · View at Scopus
  78. D. Dlugovitzky, A. Torres-Morales, L. Rateni et al., “Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement,” FEMS Immunology and Medical Microbiology, vol. 18, no. 3, pp. 203–207, 1997. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Dlugovitzky, M. L. Bay, L. Rateni et al., “In vitro synthesis of interferon-γ, interleukin-4, transforming growth factor-β and interleukin-1β by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement,” Scandinavian Journal of Immunology, vol. 49, no. 2, pp. 210–217, 1999. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Torres, T. Herrera, H. Villareal, E. A. Rich, and E. Sada, “Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis,” Infection and Immunity, vol. 66, no. 1, pp. 176–180, 1998. View at Google Scholar · View at Scopus
  81. A. J. Wolf, B. Linas, G. J. Trevejo-Nuñez et al., “Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo,” Journal of Immunology, vol. 179, no. 4, pp. 2509–2519, 2007. View at Google Scholar · View at Scopus
  82. S. A. Khader, S. Partida-Sanchez, G. Bell et al., “Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection,” Journal of Experimental Medicine, vol. 203, no. 7, pp. 1805–1815, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. C. Demangel, P. Bertolino, and W. J. Britton, “Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production,” European Journal of Immunology, vol. 32, no. 4, pp. 994–1002, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. J. Jung, L. Ryan, R. LaCourse, and R. J. North, “Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice,” Journal of Experimental Medicine, vol. 201, no. 12, pp. 1915–1924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. L. Fan, H. Xiao, Z. Hu, and J. D. Ernst, “Variation of Mycobacterium tuberculosis antigen-specific IFN-c and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects,” PLoS ONE, no. 8, Article ID e42716, 2012. View at Publisher · View at Google Scholar
  86. D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, “Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones,” Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081–2095, 1989. View at Publisher · View at Google Scholar · View at Scopus
  87. R. de Waal Malefyt, H. Yssel, and J. E. de Vries, “Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation,” Journal of Immunology, vol. 150, no. 11, pp. 4754–4765, 1993. View at Google Scholar · View at Scopus
  88. L. Schandene, C. Alonso-Vega, F. Willems et al., “B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10,” Journal of Immunology, vol. 152, no. 9, pp. 4368–4374, 1994. View at Google Scholar · View at Scopus
  89. S. A. Fulton, J. V. Cross, Z. T. Toossi, and W. H. Boom, “Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumor necrosis factor-α, and interferon-γ in human monocytes infected with Mycobacterium tuberculosis H37Ra,” Journal of Infectious Diseases, vol. 178, no. 4, pp. 1105–1114, 1998. View at Google Scholar · View at Scopus
  90. J. L. Flynn and J. Chan, “Immunology of tuberculsis,” Annual Review of Immunology, vol. 19, pp. 93–129, 2001. View at Publisher · View at Google Scholar
  91. A. D'Andrea, M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri, “Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells,” Journal of Experimental Medicine, vol. 178, no. 3, pp. 1041–1048, 1993. View at Google Scholar · View at Scopus
  92. P. J. Murray and R. A. Young, “Increased antimycobacterial immunity in interleukin-10-deficient mice,” Infection and Immunity, vol. 67, no. 6, pp. 3087–3095, 1999. View at Google Scholar · View at Scopus
  93. G. L. Beamer, D. K. Flaherty, B. D. Assogba et al., “Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice,” Journal of Immunology, vol. 181, no. 8, pp. 5545–5550, 2008. View at Google Scholar · View at Scopus
  94. M. I. Henao, C. Montes, S. C. París, and L. F. García, “Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis,” Tuberculosis, vol. 86, no. 1, pp. 11–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. V. A. Boussiotis, E. Y. Tsai, E. J. Yunis et al., “IL-10-producing T cells suppress immune responses in anergic tuberculosis patients,” Journal of Clinical Investigation, vol. 105, no. 9, pp. 1317–1325, 2000. View at Google Scholar · View at Scopus
  96. R. E. Rojas, K. N. Balaji, A. Subramanian, and W. H. Boom, “Regulation of human CD4+αβ T-cell-receptor-positive (TCR+) and γδ TCR+ T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β,” Infection and Immunity, vol. 67, no. 12, pp. 6461–6472, 1999. View at Google Scholar · View at Scopus
  97. A. S. Almeida, P. M. Lago, N. Boechat et al., “Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity,” Journal of Immunology, vol. 183, no. 1, pp. 718–731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. R. E. Weir, G. F. Black, H. M. Dockrell et al., “Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor α, interleukin-1β (IL-1β), and IL-10 responses compared to those of adolescents in the United Kingdom,” Infection and Immunity, vol. 72, no. 3, pp. 1807–1811, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. H. D. Shin, B. L. Park, L. H. Kim, H. S. Cheong, I. H. Lee, and S. K. Park, “Common interleukin 10 polymorphism associated with decreased risk of tuberculosis,” Experimental and Molecular Medicine, vol. 37, no. 2, pp. 128–132, 2005. View at Google Scholar · View at Scopus
  100. C. B. Pereira, M. Palaci, O. H. M. Leite, A. J. S. Duarte, and G. Benard, “Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations,” Microbes and Infection, vol. 6, no. 1, pp. 25–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. A. A. Awomoyi, A. Marchant, J. M. M. Howson, K. P. W. J. McAdam, J. M. Blackwell, and M. J. Newport, “Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis,” Journal of Infectious Diseases, vol. 186, no. 12, pp. 1808–1814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. J. F. McDyer, M. N. Hackley, T. E. Walsh, J. L. Cook, and R. A. Seder, “Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses,” Journal of Immunology, vol. 158, no. 1, pp. 492–500, 1997. View at Google Scholar · View at Scopus
  103. C. E. Gazeta, M. L. S. Santos G, S. H. F. Vendramini, J. M. Pinto Neto, and T. C. S. Villa, “Controle de comunicantes de tuberculose no Brasil: Revisão de literatura (1984–2004),” Revista Latino-Americana de Enfermagem, vol. 16, no. 2, pp. 306–313, 2008. View at Google Scholar
  104. A. Demissie, M. Abebe, A. Aseffa et al., “Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2,” Journal of Immunology, vol. 172, no. 11, pp. 6938–6943, 2004. View at Google Scholar · View at Scopus
  105. A. Demissie, L. Wassie, M. Abebe et al., “The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of γ interferon,” Infection and Immunity, vol. 74, no. 5, pp. 2817–2822, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. Y. V. N. Cavalcanti, V. R. A. Pereira, L. C. Reis et al., “Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases,” Journal of Clinical Laboratory Analysis, vol. 23, no. 1, pp. 57–62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. J. O. Olobo, M. Geletu, A. Demissie et al., “Circulating TNF-α, TGF-β, and IL-10 in tuberculosis patients and healthy contacts,” Scandinavian Journal of Immunology, vol. 53, no. 1, pp. 85–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. S. A. Sharpe, E. Eschelbach, R. J. Basaraba et al., “Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis,” Tuberculosis, vol. 89, no. 6, pp. 405–416, 2009. View at Publisher · View at Google Scholar · View at Scopus